Olorunsola, E.O.; Davies, K.G.; Essien, E.B.; Alozie, M.F.; Adedokun, M.O.; Ahsan, F.
Orally Administered Prosochit®-Based Nanoparticles of Insulin Ameliorates Alloxan-Induced Diabetes in Rats. Sci. Pharm. 2022, 90, 66.
https://doi.org/10.3390/scipharm90040066
AMA Style
Olorunsola EO, Davies KG, Essien EB, Alozie MF, Adedokun MO, Ahsan F.
Orally Administered Prosochit®-Based Nanoparticles of Insulin Ameliorates Alloxan-Induced Diabetes in Rats. Scientia Pharmaceutica. 2022; 90(4):66.
https://doi.org/10.3390/scipharm90040066
Chicago/Turabian Style
Olorunsola, Emmanuel O., Koofreh G. Davies, Enomfon B. Essien, Mfonobong F. Alozie, Musiliu O. Adedokun, and Fakhrul Ahsan.
2022. "Orally Administered Prosochit®-Based Nanoparticles of Insulin Ameliorates Alloxan-Induced Diabetes in Rats" Scientia Pharmaceutica 90, no. 4: 66.
https://doi.org/10.3390/scipharm90040066
APA Style
Olorunsola, E. O., Davies, K. G., Essien, E. B., Alozie, M. F., Adedokun, M. O., & Ahsan, F.
(2022). Orally Administered Prosochit®-Based Nanoparticles of Insulin Ameliorates Alloxan-Induced Diabetes in Rats. Scientia Pharmaceutica, 90(4), 66.
https://doi.org/10.3390/scipharm90040066